Literature DB >> 23663184

Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study.

J Garau1, H Ostermann, J Medina, M Avila, K McBride, F Blasi.   

Abstract

Complicated skin and soft tissue infections (cSSTI) are common and frequently require treatment in hospital. Comprehensive current data on management practices in patients hospitalized with cSSTI are limited. REACH was a retrospective, observational cohort study designed to provide data on current clinical management of moderate to severe cSSTI in European hospitals. Data were collected via an electronic case report form from 129 sites in ten European countries. The study population comprised patients ≥18 years, hospitalized between March 2010 and February 2011 with cSSTI who received intravenous antibiotic treatment. Presented here is an analysis of the disease characteristics, treatment patterns during hospitalization and clinical outcomes identified by the study. The total population included 1995 patients (mean age 60.6 years; 57.7% male). Initial antibiotic treatment modification was reported in 39.6% (n = 791) of patients; it was more common in patients with co-morbidities (42.6%), those requiring surgical intervention (43.4%), those with more severe infections such as bacteraemia (51.6%) or with fascia affected (49.0%), those admitted to the intensive care unit (56.2%) and those with lesions > 50 cm(2) (44.3%). A switch to narrower-spectrum antibiotic treatment (streamlining) occurred in 5.6% of patients. Mean length of hospital stay was 18.5 days (±19.9; median 12.0) and the total mortality rate was 3.4%. The data collected in REACH give a comprehensive and current view of real-life clinical management of cSSTI in European hospitals and provide evidence of a high rate of initial antibiotic treatment modification. ©2013 The Authors Clinical Microbiology and Infection ©2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Antibiotic; Europe; complicated skin and soft tissue infections; epidemiology; hospitalized; management; moderate-to-severe; observational; outcomes; treatment modification

Mesh:

Substances:

Year:  2013        PMID: 23663184     DOI: 10.1111/1469-0691.12235

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  35 in total

Review 1.  Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.

Authors:  Abraham Pulido-Cejudo; Mario Guzmán-Gutierrez; Abel Jalife-Montaño; Alejandro Ortiz-Covarrubias; Jose Luis Martínez-Ordaz; Héctor Faustino Noyola-Villalobos; Luis Mauricio Hurtado-López
Journal:  Ther Adv Infect Dis       Date:  2017-08-31

2.  Comparison of the microbiology and antibiotic treatment among diabetic and nondiabetic patients hospitalized for cellulitis or cutaneous abscess.

Authors:  Timothy C Jenkins; Bryan C Knepper; S Jason Moore; Carla C Saveli; Sean W Pawlowski; Daniel M Perlman; Bruce D McCollister; William J Burman
Journal:  J Hosp Med       Date:  2014-09-30       Impact factor: 2.960

Review 3.  Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.

Authors:  James E Frampton
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

Review 4.  Oritavancin: a review in acute bacterial skin and skin structure infections.

Authors:  Yahiya Y Syed; Lesley J Scott
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

Review 5.  [Bacterial skin and soft tissue infections].

Authors:  Frank Hanses
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

6.  Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies.

Authors:  G Ralph Corey; Jeffery Loutit; Greg Moeck; Matthew Wikler; Michael N Dudley; William O'Riordan
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 7.  Oritavancin for acute bacterial skin and skin structure infections.

Authors:  Julia A Messina; Vance G Fowler; G Ralph Corey
Journal:  Expert Opin Pharmacother       Date:  2015-03-24       Impact factor: 3.889

Review 8.  Diagnosis and management of skin and soft tissue infections in the intensive care unit: a review.

Authors:  Jason P Burnham; John P Kirby; Marin H Kollef
Journal:  Intensive Care Med       Date:  2016-10-03       Impact factor: 17.440

9.  Inpatient Management of Uncomplicated Skin and Soft Tissue Infections in 34 Veterans Affairs Medical Centers: A Medication Use Evaluation.

Authors:  Jesse D Sutton; Ronald Carico; Muriel Burk; Makoto M Jones; XiangMing Wei; Melinda M Neuhauser; Matthew Bidwell Goetz; Kelly L Echevarria; Emily S Spivak; Francesca E Cunningham
Journal:  Open Forum Infect Dis       Date:  2020-01-27       Impact factor: 3.835

10.  Etiology of Cellulitis and Clinical Prediction of Streptococcal Disease: A Prospective Study.

Authors:  Trond Bruun; Oddvar Oppegaard; Bård R Kittang; Haima Mylvaganam; Nina Langeland; Steinar Skrede
Journal:  Open Forum Infect Dis       Date:  2015-11-25       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.